EVEROLIMUS

NDC 72603-255 · NorthStar RxLLC

Generic nameeverolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength5 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

72603-255-01 — 30 TABLET in 1 BOTTLE (72603-255-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70377-012 — everolimus, 70377-013 — everolimus, 70377-069 — Everolimus, 70377-070 — EVEROLIMUS, 70377-071 — everolimus, 70377-090 — Everolimus, 70377-091 — Everolimus, 70377-092 — Everolimus, 70377-112 — everolimus, 72603-254 — everolimus, 72603-256 — everolimus, 72603-257 — everolimus, 82249-610 — Everolimus, 82249-611 — Everolimus, 82249-612 — Everolimus, 82249-613 — Everolimus, 82293-030 — everolimus, 82293-031 — everolimus, 82293-032 — everolimus, 82293-033 — everolimus, +63 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources